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A novel, yet undescribed phenomenon is that hyphae can grow but they 
can not produce sporangiola in the inhibition zone in the case of M. 
elongata. F8AP had no effect on bacterial growth (examined: Bacillus 
subtilis, Escherichia coli, Micrococcus luteus, Serratia marcescens).
In silico examination revealed the physical and chemical 
properties of F8AP: it is small molecular mass (6357.16 Da), basic (pI= 
9.26) protein consisting of 55 amino acids, which contains two domains 
and is stabilized by three disulfide bridges. The tertiary and quaternary 
structure of the protein (based on the presumed 3D model of F8AP) is very 
similar the defenzin-like molecules: 2 β-sheets connected by one α-helix.
Construction of a heterolog expression system for a novel
antimicrobial protein
The f8ap gene was built into the pPICZαA vector and transformed 
into Pichia pastoris. F8AP expression was observed when methanol was 
added into the medium. Purified F8AP from the supernatant maintained its 
biological activity.
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membrane perturbation and intracellular oxidative stress. The effect of 
PAF on fungal species has been investigated on a very limited number of 
isolates until now, and its ability to cooperate with any antifungal drugs 
has not been revealed yet (Marx, 2004). The Rhizopus microsporus var. 
oligosporus antibiotic peptide encoded by two genes (abp1 and abp2) has 
an antibacterial effect against Bacillus spp. only. ABP1 of the both is the 
biologically active form (Kobayashi et al., 1992; Yamada et al., 2005).
The aims of this study
The aims of this study were:
1. To investigate the effect of PAF on some practically important 
fungal isolates.
2. To investigate the possible interactions between statins and 
PAF against various PAF/statin sensitive Zygomycetes.
3. To investigate the possible antifungal effect of PAF-
fluconazole combination against dermatophyte species.
4. To determine the presence of possible novel antimicrobial 
proteins and their encoding genes in the case of F-, R- and A-isolates.
5. To optimize the expression of a novel antimicrobial protein.
6. To develop a procedure for the isolation and purification of the 
novel antimicrobial peptides, and for the determination of its antimicrobial 
spectrum.
7. To create a heterolog expression system for the novel
antimicrobial protein.
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Determination of the presence of possible novel antimicrobial proteins 
and their encoding genes
Fifteen F-isolates representing 10 species have been screened via 
PCR experiments. Sequences corresponding to hypothetical defensin-like 
proteins have been found in all isolates. These revealed high similarity to 
the nucleic acid sequence of the gama gene. Taking into account their 
nucleic acid and hypothetical protein sequences, 6 types of antifungal 
proteins could be differentiated. Aside from the possible signal sequences, 
only 3 novel antifungal protein groups were detectable: F7, F2 and F5/a-d, 
F1.
The presence of abp1-2 gene was observed in 12 R-isolates 
representing 6 species. The percentage of homology between the DNA 
sequences was 100% to abp1 and abp2.
We also examined A-isolates representing 7 species. One, non 
functional afp/anafp homologue mutant gene was detected in the case of 
the A6-isolate. An AFP-similar protein encoding gene was established in 
the case of A2-isolate, which carries one amino acid mutation in its 
hypothetical signal sequence compared to AFP.
The presence of defensin-like antifungal proteins is more frequent 
among filamentous fungi than presumed before.
Optimization of the expression of a novel antimicrobial protein
The production of antifungal poteins in the case of F-isolates has 
been optimized with using of antifungal protein induction medium. Their 
biological activities on hyphal growth of Trichoderma longibrachiatum
and Mortierella elongata was investigated with an agar diffusion 
technique. The extracts of eight of ten species showed similar
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Syncephalastrum racemosum and Saksenaea vasiformis proved to be 
insensitive to PAF. Similar results were observed in PAF-treated Hypocrea 
orientalis, Trichoderma atroviride, T. citrinoviride, T. harzianum, T. 
inhamatum and T. longibrachiatum. Only the T. viride isolate was 
insensitive to influence of PAF, and the rate of inhibition in case of T. 
harzianum and T. inhamatum depended on the applied medium. Sprawling 
hyphae were observed in the region of earlier inhibition zones after 48 or 
72 hours of incubation depending on the applied medium. All pathogenic 
yeast isolates (Candida albicans, C. glabrata, C. guilliermondii, C. 
inconspicua, C. krusei, C. lipolytica, C. lusitaniae, C. norvegica, C. 
tropicalis, C. parapsilosis, C. pulcherrima, C. zeylanoides and Malassezia 
pachydermatis) proved to be insensitive species to PAF treatment. Higher 
concentrations of PAF (≥50 μg/ml) were effective in inhibiting the growth 
of dermatophytes (Trichophyton mentagrophytes, T. rubrum, T. tonsurans, 
Microsporum canis, M. gypseum) and fungicidal effect was observed in 
every cases at 200 μg/ml of PAF.
Interaction between PAF and statins
The effects of combination of statins with PAF were investigated 
on four isolates of Zygomycetes (Rhizopus stolonifer, Mortierella wolfii, 
Syncephalastrum racemosum and Mycotypha africana) which represented 
combinations of lovastatin sensitive/insensitive and PAF 
sensitive/insensitive properties based on preliminary experiments. The 
efficiency to inhibit sporangiospore germination was studied with 4 statins 
(lovastatin, simvastatin, rosuvastatin, atorvastatin) at different 
concentrations (1-128 μg/ml) with a constant concentration of PAF (50 
μg/ml) in in vitro experiments. Interactions were not found in R. stolonifer.
This species was completely insensitive to both lovastatin and PAF.
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Introduction
The number of microbial infections has increased continuously 
over the past years in consequence of increasing number of immunocom-
promised patients and inefficient using of of broad-spectrum antifungal 
drugs (Ribes et al., 2000). Infections caused by opportunistic filamentous
fungi are especially problematic, because most of the antifungal treatments 
available have serious side effects and could not be applied without a 
damage of the host (Vicente et al., 2003). Therefore, there is a substantial 
demand for new types of compounds with antifugal activity.
The pest controll has some challenge to defense against fungal 
infections. Its aim is the keeping or enhancing of yield with using of 
effective antifungal compounds. The requirement of these kinds of agents 
is that they should not do harm to the enviroment, plants, animals and 
human. Other aspect, is that they should be produced at a low of price.
The extracellular antimicrobial proteins secreted by some filamen-
tous fungi are interesting from this respect, as they have effective inhibi-
tory potential as concerns both the hyphal extension and the germination of 
the spores. The features of these proteins are a low molecular mass (5.8-6.6 
kDa), a basic character, and the presence of 6-8 cysteine residues and sev-
eral disulfide bonds. Proteins with such properties with antifungal activity 
have been isolated and investigated from 5 fungal species (Penicillium 
chrysogenum, P. nalgiovense, Aspergillus clavatus, A. giganteus and A. 
niger), furthermore, in silico investigation of genomic databases has been 
revealed a putative protein with high homology to P. chrysogenum anti-
fungal protein (PAF) in Gibberella zeae. It has been shown that, in sensi-
tive fungi, PAF is localized intracellularly and exerts multiple detrimental 
effects: induction of morphological changes, 
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Summary
Our results have revealed:
1. PAF-sensitivity of some practically important fungal isolates 
including human pathogenic clinical isolates.
2. Effective interaction between PAF and statins and antifungal 
activity of the observed statins.
3. Effective interaction between PAF and statins against 
dermatophyte isolates.
4. The presence of defensin-like antifungal proteins is more frequent 
among filamentous fungi than presumed before.
5. Some investigated novel antifungal proteins may be regarded as 
promising candidates in future antifungal drug research.
6. Presence of a small molecular mass antifungal protein in the case 
of F8-isolate (F8AP), which maintained its antifungal activity 
after the purification.
7. Pichia pastoris can synthetise the F8AP in a biologically active 
form.
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Methods
- In vitro antifungal susceptibility tests
- Assays for in vitro antifungal drug interactions
- DNA and RNA techniques
- Polymerase chain reaction (PCR)
- Inverse PCR
- DNA sequencing
- Techniques for the production and purification of novel antifungal 
proteins
- Protein gel electophoresis
- Isoelectric focusing protein gel electrophoresis
- In silico methods
- Heterolog expression (EasySelectTM Pichia Expression Kit,
Invitrogen)
Results
The effect of PAF on some practically important fungal isolates
PAF treatment (50 μg/ml) resulted in a strong inhibition of the 
germination of spores and the hyphal extension in the case of Absidia 
corymbifera, Micromucor ramanniana, Mortierella elongata, M. 
nanthalensis, M. wolfii, Mycotypha africana, Rhizomucor miehei, R. 
pusillus, Rhizopus microsporus var. oligosprus, R. oryzae, Thamnostylum 
piriforme, Umbellopsis isabellina, Zygorhynchus macrocarpus. 
Actinomucor elegans, Cokeromyces recurvatus, Gilbertella persicaria,
Mucor hiemalis f. luteus, M. racemosus, Rhizopus stolonifer,
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inhibitory effect like PAF, while the ferment broth of two isolates (F1 and
F5/a) proved to be inactive in these tests. The supernatant of F8 was the 
most effective in the inhibition of hyphal extension.
Developing of a procedure for the isolation and purification of a novel
antimicrobial peptides, and for the determination of its antimicrobial 
spectrum
Protein gel electrophoresis revealed the presence of a small prote-
in (approximately 6.3 kDa) in the eight biologically active species. These 
proteins were purified further with ultrafiltration and ion exhcange 
chromatography on a CM-sepharose column. The purified protein of F8-
isolate maintained its antimicrobial activity. It was determined with several 
tests against Trichoderma longibrachiatum and Mortierella elongata, that 
this ~6.3 kDa protein is responsible for the antifungal activity, and it was 
named F8-isolate antifungal protein (F8AP). The effect of F8AP on germi-
nation efficiency of sensitive conidiospores was examined in T. longi-
brachiatum. The conidiospores displayed abnormal and delayed germina-
tion when cultivated in an F8AP-containing medium. F8AP-treated co-
nidiospores formed very short, swelled hyphae with multiple branches.
F8AP treatment (50 μg/ml) resulted in the inhibition of growth in the cases 
of most of the 18 examined Zygomycetes and the 11 yeasts and 4 
filamentous fungi from Ascomycetes. The species specifity of F8AP was 
the same as that of PAF in most of the cases, but differences were observed 
in the case of Candida spp.: C. inconspicua, C. lipolytica, C. lusitaniae, C. 
norvegica and C. parapsilosis were slightly sensitive. However, it has to be 
mentioned that there were differences in the applied test methods. 
Sprawling hyphae were not observed in the region of earlier inhibition 
zones in the case of Trichoderma/Hypocrea species like in case of PAF.
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The inhibitions induced by the combinations of simvastatin-PAF, rosuvas-
tatin-PAF and atorvastatin-PAF were the same as those observed for the 
statins alone. M. wolfii was practically insensitive to the applied statins. 
The approximately 40% decrease in the growth of M. wolfii in the presence 
of the statin-PAF combinations corresponds with the activity of PAF ap-
plied without a statin. For S. racemosum, no interaction between lovastatin 
and PAF was detected: there was no significant difference between sensi-
tivity to lovastatin or lovastatin-PAF. Simvastatin at 4 μg/ml acted syner-
gistically with PAF, decreasing the growth rate to 17% (±2%). Higher 
concentrations of simvastatin added together with PAF led to the total 
inhibition of growth. Rosuvastatin acted synergistically with PAF even at 
low statin concentrations (≥2 μg/ml); but it is worth to mention that rosu-
vastatin alone can evoke a complete growth inhibition at concentrations 
above 32 μg/ml. Atorvastatin acted synergistically with PAF on S. racemo-
sum at 1-8 μg/ml concentrations, and additively at 16 μg/ml of atorvastatin; 
higher statin concentrations combined with PAF resulted in complete 
growth inhibition. M. africana was sensitive to all statins and PAF, and the 
inhibition was increasing when the two types of compounds were applied 
in combinations. Synergistic interactions were detected between lovastatin 
(at 1-8 μg/ml) and PAF. The addition of 8 μg/ml lovastatin together with 
PAF reduced the growth rate to 8% (±0.8%); higher concentrations re-
sulted in further slight decreases in the growth, but complete inhibition was 
not achieved. Simvastatin interacted additively with PAF at 1-4 μg/ml. 
However, no effect of PAF was detected at higher simvastatin concentra-
tions: the inhibition rates were the same as those with the same amounts of 
simvastatin without PAF. One μg/ml of rosuvastatin and PAF acted syner-
gistically against M. africana, causing an inhibition of 92% (±0.2%). Addi-
tive interactions were observed at 2-4 μg/ml; higher rosuvastatin concen-
trations led to complete growth 
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inhibition. Atorvastatin at 1-4 μg/ml acted additively with PAF; higher 
concentrations in the presence of PAF inhibited germination completely. 
The inhibition rates obtained with the rosuvastatin-PAF and atorvastatin-
PAF combinations were very similar. In conclusion, the activities of the 
statin-PAF combinations on the different strains varied and depended con-
siderably on the activities of the components alone. When a strain was 
resistant to one of the components, e.g. R. stolonifer to PAF or M. wolfii to 
the statins, significant interactions could not be detected; only the effect of 
the active component was observed.
Interaction between PAF and fluconazole
A constant concentration of PAF (100 μg/ml) combined with 
eight different (0.25-32 μg/ml) concentrations of fluconazole (FCZ) was 
investigated against dermatophytes. The activities of PAF-fluconazole 
combinations on different strains varied and depended on the activities of 
the components alone. Trichophyton rubrum and T. tonsurans were the 
most sensitive species to PAF-fluconazole combinations. Synergistic inter-
actions were detected betweeen PAF and fluconazole at 8-16 μg/ml and 32 
μg/ml in several cases. PAF interacted additively with fluconazole at 4-2 
μg/ml for T. rubrum, and 16-4 μg/ml of fluconazole in the case of T. ton-
surans. For T. mentagrophytes and Microsporum canis, additive interac-
tions were detected between the two compounds at ≥8 μg/ml of flucona-
zole. Interactions were not found in the case of M. gypseum, only the effect 
of PAF or fluconazole was detectable. Fluconazole was dominant ranging 
from 32 μg/ml to 8 μg/ml, than the influence of PAF was prevailed. The 
fungistatical effect of fluconazole at 32 μg/ml in the case of T. rubrum and 
M. canis turned into fugicidical when 100 μg/ml of PAF was added.
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